Why Lantheus (LNTH) Stock Is Falling Today

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

LNTH Cover Image

What Happened?

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ: LNTH) fell 3.1% on continued negative momentum after a downgrade by Truist Securities, which cited concerns over competitive pressures and weaker-than-expected second-quarter results. The downgrade from "Buy" to "Hold" by Truist Securities included a significant price target reduction to $63 from $111. 

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Lantheus? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Lantheus’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was about 21 hours ago when the stock dropped 4.7% on the news that Truist Securities downgraded the stock from a "Buy" to a "Hold" rating and slashed its price target by over 43%. The downgrade, which cut the price target to $63 from $111, was driven by concerns over the performance of Lantheus's key radiopharmaceutical product, PYLARIFY. This follows the company's disappointing second-quarter results, where it missed both revenue and earnings estimates. Revenue fell 4.1% year-over-year to $378 million due to competitive pricing pressures. Compounding the issue, Lantheus also lowered its full-year financial guidance for revenue and earnings, signaling expectations for continued headwinds. The combination of missed Q2 targets, a reduced outlook, and the subsequent analyst downgrade has soured investor sentiment.

Lantheus is down 40% since the beginning of the year, and at $53.25 per share, it is trading 54.4% below its 52-week high of $116.69 from October 2024. Investors who bought $1,000 worth of Lantheus’s shares 5 years ago would now be looking at an investment worth $3,935.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.05
+4.35 (1.74%)
AAPL  269.13
+5.74 (2.18%)
AMD  276.75
-1.51 (-0.54%)
BAC  54.19
+0.68 (1.26%)
GOOG  334.75
+1.99 (0.60%)
META  685.09
+8.22 (1.21%)
MSFT  424.56
+4.30 (1.02%)
NVDA  201.14
+2.79 (1.41%)
ORCL  181.97
+3.63 (2.04%)
TSLA  394.37
+5.47 (1.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.